Glenmark launches injection for prevention of chemotherapy-induced nausea, vomiting in India
23 Jan 2023
Glenmark Pharmaceuticals announced on Monday that it was the first pharmaceutical company in India to launch Akynzeo, an intravenous injection formulation for the prevention of chemotherapy-induced nausea and vomiting (CINV), under an exclusive licencing agreement with Helsinn, a Swiss biopharma group company. It is a ready-to-dilute IV injection that contains...
Read More